NSEGeneral Updates24 Jun 2026 · 24 Jun 2026, 05:48 pm

General Updates

Medplus Health Services Limited · MEDPLUS

✦ AI Summary▼ NegativeRegulatory

MedPlus Health Services Limited has received two suspension orders for a Drug License of a store situated in the state of Andra Pradesh. The suspension is for seven days and may impact the company's revenue by Rs 1.92 lacs and Rs 1.00 lacs respectively.

Analysis Scores

Earnings Impact6/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

MEDPLUS_24062026174525_Intimation.pdf

pdf

Download →
View document text
MedPlus Health Services Limited June 24, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received two suspension orders for a Drug License of a store situated in the state of Andra Pradesh: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Authority Nature and details of Date of receipt of Details of the Impact on the action(s) taken, direction or order, violation(s)/ financial initiated or order(s) including any contravention(s) operation or passed interim or interim committed or other activities of orders, or any alleged to be the listed entity, other committed quantifiable in communication monetary terms from the to the extent authority possible Assistant Director & District Suspension of Drug Order received on Under Rule 65 of Potential Revenue Sales Licencing & License for seven 23.06.2026 Drugs and Cosmetics Loss of Rs 1.92 Enforcement Authority, days of store situated Act, 1940 and Drugs lacs. Rajamahendravaram, East at Kovvada Main and Cosmetics Rules, Godavari District, Andra Road, Andra Pradesh. 1945 Pradesh. Assistant Director, District Suspension of Drug Potential Revenue Sales licensing Authority, License for seven Loss of Rs 1.00 Drugs Control Administration, days of store situated lacs. Kurnool & Nandyal District, at Bethemcherla Andra Pradesh. Main Road, Andra Pradesh. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Gangadi Madhukar Reddy Managing Director and Chief Executive Officer DIN: 00098097 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com